TScan Therapeutics, Inc. — Director's Dealing 2021

Jul 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TScan Therapeutics, Inc. (TCRX)
CIK: 0001783328
Period of Report: 2021-07-20

Reporting Person: BARBERICH TIMOTHY J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-20	Voting Common Stock	C	33259	—	Acquired	33259	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-20	Series B Preferred Stock	$	C	33259	Disposed		Voting Common Stock (33259)	Direct

Footnotes

F1: Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.